Skip Nav Destination
1-10 of 10
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway
Michael J. Krisinger, Verena Goebeler, Zhen Lu, Scott C. Meixner, Timothy Myles, Edward L. G. Pryzdial, Edward M. Conway
Blood (2012) 120 (8): 1717–1725.
Includes: Supplemental data
Waveform Analysis Extends the Capabilities of aPTT and PT Clotting Assays for Detecting Factor Deficiency and Monitoring Procoagulant Drug Therapy
Lilley Leong, PhD, MS, Xiaoqiao Jiang, BS, Jill Cifrese, MS, John E. Murphy, PhD, Jesper Haaning, PhD, Timothy Myles, PhD
Blood (2011) 118 (21): 1205.
Blood (2009) 114 (22): 3591.
Differentially Cleaved Forms of Osteopontin by Thrombin and Carboxypeptidase B (TAFIa) Regulates Neutrophil Viability and Synoviocyte Binding in Rheumatoid Arthritis
Shadi Sharif, MS, Xiaoyan Du, PhD, Timothy Myles, PhD, Jason Jungsik Song, MD, Elizabeth A Price, MD, MPH, David Lee, MD, PhD, Stuart Goodman, MD, John Morser, PhD, William Robinson, MD, PhD, Lawrence L. Leung, MD
Blood (2008) 112 (11): 3562.
Thrombin-Cleaved Osteopontin Is Regulated by Thrombin-Activatable Carboxypeptidase B in Rheumatoid Arthritis.
Timothy Myles, PhD, Shadi A. Sharif, BS, Xiao-Yan Du, PhD, Jason J. Song, MD, Price Elizabeth, MD, William H. Robinson, MD, Lawrence L. Leung, MD
Blood (2007) 110 (11): 1744.
Toshihiko Nishimura, Timothy Myles, Adrian M. Piliposky, Peter N. Kao, Gerald J. Berry, Lawrence L. K. Leung
Blood (2006) 109 (5): 1992–1997.
Keiji Nogami, M.D./Ph. D., Qian Zhou, Hironao Wakabayashi, Ph.D., Timothy Myles, Ph.D., Lawrence L. Leung, M. D., Philip J. Fay, Ph. D.
Blood (2004) 104 (11): 1711.
Toshihiko Nishimura, MD, Timothy Myles, PhD, Mariko Nagashima, PhD, John Morser, PhD, Ronald G. Pearl, MD, Lawrence L.K. Leung, MD
Blood (2004) 104 (11): 2973.
Essential Thrombin Residues for Inhibition by Plasminogen Activator Inhibitor-1 in the Absence and Presence of Heparin and Vitronectin.
Yolanda M. Fortenberry, Ph.D., Jill C. Rau, Lauren C. Cranford, Timothy Myles, Ph.D., Lawerence L. Leung, M.D., Frank C. Church, Ph.D.
Blood (2004) 104 (11): 3986.
Blood (2002) 100 (8): 2820–2826.